BENNANI YOUSSEF L.,ROBARGE MICHAEL J.,BOM DAVID C.,VARGA NORBERT,TUMEY LAWRENCE N.,BENNANI Youssef L.,ROBARGE Michael J.,BOM David C.,VARGA Norbert,TUMEY Lawrence N.
申请号：
SI200531663
公开号：
SI1778243T1
申请日:
2005.06.29
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
